XFOR
X4 Pharmaceuticals Inc
2.90$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | 0.00 | 7.63 | 7.81 | 4.48 | 0.00 | 0.00 | 0.00 | 0.38 | 0.83 | |
| 38.27 | 22.67 | 102.15 | 0.22 | 1.75 | 1.84 | 2.20 | 0.94 | 0.34 | 0.12 | 0.15 | |
| -38.27 | -22.67 | -102.15 | -0.22 | -1.75 | 4.48 | -2.20 | -0.94 | -0.34 | 0.26 | 0.68 | |
| 1,215.77 | 1,347.26 | 14,734.42 | 44.33 | 78.48 | 62.66 | 56.80 | 28.83 | 12.15 | 12.18 | 1.71 | |
| 202.76 | 492.26 | 4,193.29 | 40.10 | 45.90 | 31.29 | 28.78 | 12.76 | 5.42 | 9.18 | 1.03 | |
| 1,380.25 | 1,816.85 | 18,825.56 | 63.14 | 120.03 | 93.95 | 85.58 | 41.35 | 18.14 | 5.69 | 2.74 | |
| -1,418.52 | -1,839.52 | -18,927.71 | -63.37 | -121.78 | -89.47 | -87.79 | -41.35 | -18.14 | -5.43 | -2.05 | |
| 45.16 | 190.03 | 1,089.05 | 1.57 | 5.59 | 4.02 | 4.24 | 1.89 | 0.97 | 1.31 | 0.21 | |
| -1,264.76 | -1,735.93 | -17,745.94 | -72.52 | -137.40 | -92.62 | -103.32 | -44.32 | -17.06 | -5.54 | -1.87 | |
| 37.80 | 197.88 | 978.52 | 8.50 | 9.88 | 0.22 | 0.02 | 0.01 | 0.01 | 0.05 | 0.00 | |
| -1,264.76 | -1,735.93 | -17,745.94 | -72.52 | -137.40 | -92.84 | -103.34 | -44.33 | -17.07 | -5.59 | -1.87 | |
| -1,380.25 | -1,816.85 | -18,825.56 | -63.14 | -120.03 | -88.94 | -96.87 | -42.19 | -16.01 | -4.11 | -1.63 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.